Amyloid-β oligomers induce synaptic damage via Tau-dependent microtubule severing by TTLL6 and spastin

Hans Zempel1, Julia Luedtke, Yatender Kumar

  • 1DZNE, German Center for Neurodegenerative Diseases, Bonn, Germany.

The EMBO Journal
|September 26, 2013
PubMed

Insights

Alzheimer disease involves Tau protein missorting into dendrites, causing microtubule (MT) breakdown and neuronal damage. Stabilizing MTs may offer a therapeutic strategy against this neurodegenerative condition.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Molecular Biology

Background:

  • Alzheimer disease (AD) is characterized by amyloid-beta (Aβ) and Tau pathology, synaptic loss, and microtubule (MT) instability.
  • Understanding the interplay between Aβ, Tau, and MT dynamics is crucial for developing effective AD therapies.

Purpose of the Study:

  • To investigate the mechanisms underlying Aβ-induced Tau missorting and subsequent MT breakdown in neurons.
  • To identify key molecular players involved in Tau/MT system alterations in AD pathogenesis.
  • To explore the therapeutic potential of MT stabilization in AD.

Main Methods:

  • Primary neuron cultures exposed to Aβ oligomers.
  • Analysis of Tau/MT system dynamics, including Tau localization, MT stability, and synaptic integrity.
  • Utilized Tau-knockout (TauKO) mouse models and transgenic mice overexpressing Tau.
  • Investigated the roles of spastin, Tubulin-Tyrosine-Ligase-Like-6 (TTLL6), and Microtubule-Affinity-Regulating-Kinase (MARK).

Main Results:

  • Aβ oligomers induce Tau missorting into dendrites, leading to MT breakdown mediated by spastin recruitment via MT polyglutamylation.
  • TTLL6 translocalization into dendrites triggers MT polyglutamylation and spastin-mediated MT severing.
  • Newly synthesized Tau, not axonally derived, is responsible for dendritic MT pathology.
  • TauKO neurons exhibit resistance to Aβ toxicity due to prevention of TTLL6 mislocalization and MT polyglutamylation.
  • MARK kinase is required for recovery from Aβ insult.
  • Tau reintroduction in TauKO neurons restores Aβ toxicity, dependent on Tau phosphorylation.
  • Tau overexpression in transgenic mice leads to TTLL6 translocalization and decreased MT stability.

Conclusions:

  • Tau missorting into dendrites is a key mechanism driving MT breakdown and synaptic loss in response to Aβ oligomers.
  • TTLL6 and spastin are critical mediators of Aβ-induced MT pathology.
  • MT stabilization emerges as a promising therapeutic strategy for Alzheimer disease.

Related Concept Videos

Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Microtubule Associated Proteins (MAPs)01:42

Microtubule Associated Proteins (MAPs)

Microtubule function and architecture are regulated by an array of specialized proteins called microtubule-associated proteins or MAPs. These proteins are widespread across different organisms and have conserved protein motifs, like the multi-TOG domain for tubulin binding found in the CLASP family of MAPs. Some MAPs are lineage-specific based on their conserved domains. Their functions depend upon the cytoskeletal architecture and cell type they are located within. In-plant cells, a specific...
Destabilization of Microtubules01:45

Destabilization of Microtubules

The destabilization of microtubules can occur during different stages of the microtubule lifecycle, such as nucleation or elongation. It can take place at either end of the microtubule or in the microtubule lattices as a whole. The lifespan of individual microtubules within a cell varies according to the cell type and stage of the cell cycle. During interphase, the lifespan of the microtubule is about 30 minutes, while during cell division, it is about 15 minutes. In axonal microtubules of...
Assembly of Complex Microtubule Structures01:32

Assembly of Complex Microtubule Structures

Complex microtubule structures are present in resting cells and in dividing cells. In resting cells, they are responsible for maintaining the cellular architecture, tracks for intracellular transport, positioning of organelles, assembly of cilia and flagella. They mediate the bipolar spindle assembly for chromosomal segregation and positioning of the cell division plate in dividing cells. The formation of microtubule complex structures depends on the cell type, cell stage, and cell function.